Total Return CAGR:34.03%(TTM)
Over the latest trailing 12-month period, total return cagr is +34.03%. The comparable SPY value is +20.46%. Year-to-date total return is +12.76%. Total return includes price appreciation and reinvested dividends.
Over longer horizons, Total Return CAGR averages -20.12% over 3 years and -12.81% over 5 years. Total return includes dividends reinvested. The total return CAGR includes both price appreciation and dividends reinvested. This gives a more complete picture of the company's investment performance.
NRC Total Return CAGR Chart
National Research Corporation (NRC)
NRC Quarterly Total Return (YoY)
Total Return Index growth vs the same quarter one year earlier, last 20 quarters.
NRC Total Return CAGR History
| Year | Start Total Return | End Total Return | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2026 | 114.73 | 129.38 | +14.64 | +12.76% | +12.76% |
| 2025 | 104.23 | 114.73 | +10.51 | +10.08% | +10.08% |
| 2024 | 229.00 | 104.23 | -124.78 | -54.49% | -54.49% |
| 2023 | 213.50 | 229.00 | +15.50 | +7.26% | +7.26% |
| 2022 | 232.59 | 213.50 | -19.09 | -8.21% | -8.21% |
| 2021 | 236.92 | 232.59 | -4.33 | -1.83% | -1.83% |
| 2020 | 363.74 | 236.92 | -126.82 | -34.86% | -34.86% |
| 2019 | 207.29 | 363.74 | +156.44 | +75.47% | +75.47% |
| 2018 | 196.75 | 207.29 | +10.55 | +5.36% | +5.36% |
| 2017 | 98.81 | 196.75 | +97.94 | +99.11% | +99.11% |
| 2016 | 81.62 | 98.81 | +17.19 | +21.06% | +21.06% |
| 2015 | 70.25 | 81.62 | +11.37 | +16.19% | +16.19% |
| 2014 | 94.10 | 70.25 | -23.85 | -25.35% | -25.35% |
Quarterly Total Return: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q2 2026 | 129 | +23.5% | +28.8% |
| Q1 2026 | 105 | -8.2% | +36.1% |
| Q4 2025 | 114 | +37.1% | +10.9% |
| Q3 2025 | 83 | -17.2% | -36.7% |
| Q2 2025 | 100 | +30.4% | -24.8% |
| Q1 2025 | 77 | -25.2% | -66.5% |
| Q4 2024 | 103 | -21.7% | -54.9% |
| Q3 2024 | 131 | -1.6% | -49.1% |
| Q2 2024 | 133 | -41.9% | -47.0% |
| Q1 2024 | 230 | +0.7% | -6.1% |
| Q4 2023 | 228 | -11.7% | +6.7% |
| Q3 2023 | 258 | +2.5% | +13.7% |
| Q2 2023 | 252 | +2.9% | +16.0% |
| Q1 2023 | 245 | +14.5% | +10.0% |
| Q4 2022 | 214 | -5.8% | -8.1% |
| Q3 2022 | 227 | +4.6% | -3.6% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About National Research Corporation
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Trent Green